
Feb 25 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE:
Q4 ADJUSTED REVENUE 5.07 BILLION EUR, +5% YOY
Q4 ADJUSTED OPERATING INCOME 489 MILLION EUR, +31% YOY
Q4 ADJUSTED NET INCOME 266 MILLION EUR
HIGH TEENS TO HIGH TWENTIES PERCENT EARNINGS GROWTH IN 2025, TRANSLATING INTO AN 11 TO 12% MARGIN
UNDERLYING U.S. SAME MARKET TREATMENT GROWTH FURTHER ACCELERATED IN Q4 AND TURNED POSITIVE FOR THE FULL YEAR
ACCUMULATED SAVINGS OF THE FME25 PROGRAM ALREADY REACHED EUR 567 MILLION AND 2025 TARGET RAISED TO EUR 750 MILLION
PLANNED DIVIDEND PROPOSAL FOR FISCAL YEAR 2024 OF EUR 1.44 PER SHARE
EXPECTS 2025 REVENUE GROWTH TO BE POSITIVE TO A LOW-SINGLE DIGIT PERCENT RATE COMPARED TO PRIOR YEAR
Further company coverage: FMEG.DE